Ionpath Launches MIBIplus and MIBIsight, A New Service Offering and User-Friendly Bioinformatics Tools, at SITC 2023

MENLO PARK, Calif.–(BUSINESS WIRE)–Ionpath, a pioneer in high-plex spatial proteomics, today announced the launch of its new service and data analysis tools for immuno-oncology applications in basic, translational, and clinical research. The service and analysis tools will be presented at the annual meeting of the Society for Immunotherapy of Cancer…
Click here to view original post